Joshua Siegel, MD
Sports Medicine · Exeter, NHNPI 1447323761
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $296,156 of the $438,495 with a category attached, or 67.5%. Anika Therapeutics, Inc. accounts for 98.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $296,156 and has fallen 100.0% since, to $21 in 2025. Among sports medicine clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 9 payments — averaging $48,722 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$433K
- Vericel Corporation$6K
- Vertex$21
- GE HealthCare$19
What the payments were for
- Consulting fees$5,5001%
- Travel & lodging$670%
- Food & beverage$400%
- Ownership interest$296,15668%
- Other$136,73231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 5 | $432,888 |
| Vericel Corporation | 2 | $5,567 |
| Vertex | 1 | $21 |
| GE HealthCare | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MACI$5,500
How this compares
$438,495 in reported general payments places this provider in the 95th percentile of 38 sports medicine providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 12 | $16 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Exeter
- Avnish ClerkExeter$89K
- Benjamin ThompsonExeter$8K
- Alexander DavisExeter$3K
- Deborah PacikExeter$2K
- Chelsea BackerExeter$217
- Joseph BernardExeter$25
- Neal GoldenbergKeene$38K
- Brendan HigginsConcord$34K
- Jason SimonNashua$9K
- David ThutSomersworth$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.